Live from the NIH registry
Studies recruiting near Poughkeepsie right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Lucian Miron Manu MD Psychiatry PC — Woodbury, New York (24.8 mi)
· Sponsor: Janssen Research & Development, LLC
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Acne Vulgaris
Phase 4
Interventional 100 participants sought
Vitality Clinical Trials, LLC — Woodbury, New York (24.8 mi)
· Sponsor: Bausch Health Americas, Inc.
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Vitality Clinical Trials — Woodbury, New York (24.8 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Carmel, New York (22.1 mi)
· Sponsor: Hoffmann-La Roche
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Nuvance Health Institute — Kingston, New York (16.5 mi)
· Sponsor: Mayo Clinic
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Hudson Valley Cardiovascular Practice PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Amgen
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
ManuMind Interventional Psychiatry — Woodbury, New York (24.8 mi)
· Sponsor: LivaNova
Examining the Most Effective Method to Reduce Running Ground Contact Time
Healthy Runners
N/A
Interventional 30 participants sought
Keller Army Community Hospital — West Point, New York (21.0 mi)
· Sponsor: Keller Army Community Hospital
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Vitality Clinical Trials LLC — Woodbury, New York (24.8 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
Novel Bioactive Sleeve on Pain and PROMs
Meniscus Tear
N/A
Interventional 100 participants sought
Orlin and Cohen Orthopedics — Woodbury, New York (24.8 mi)
· Sponsor: Northwell Health
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Vassar Brothers Medical Center/Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Inari Medical
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — New Windsor, New York (16.0 mi)
· Sponsor: GlaxoSmithKline
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Westchester Putnam Gastroenterology — Carmel, New York (22.1 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk077 — Rhinebeck, New York (16.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Medtronic
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Hudson Valley Cardiovascular Practice PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Duke University
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Hudson Valley Urology, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — New Windsor, New York (16.0 mi)
· Sponsor: AstraZeneca
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Melanoma, Glioma
Phase 1
Interventional 124 participants sought
Optum Medical Care, PC — Brewster, New York (25.9 mi)
· Sponsor: Pfizer
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Non-small Cell Lung Cancer
Phase 2, Phase 3
Interventional 1,580 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: BioNTech SE
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder, Bleeding Disorder
N/A
Observational 3,000 participants sought
Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center — Hyde Park, New York (6.2 mi)
· Sponsor: American Thrombosis and Hemostasis Network
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Vitality Clinical Research Llc — Woodbury, New York (24.8 mi)
· Sponsor: Incyte Corporation
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: DalCor Pharmaceuticals